Unknown PHASE1 INTERVENTIONAL 1-arm NCT02108132

Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia

Allogenic Mesenchymal Stem Cells in Hemophilia: a Pilot Study

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences

Interventions Cellular therapy cellular therapy

Updated 6 times since 2017 Last updated: Apr 5, 2014 Started: Aug 31, 2014 Primary completion: Aug 31, 2015 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02108132, this PHASE1 trial focuses on Hemophilia and remains ongoing. Sponsored by Affiliated Hospital to Academy of Military Medical Sciences, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE1

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Affiliated Hospital to Academy of Military Medical Sciences
Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt